These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor. Engel AG, Sakakibara H, Sahashi K, Lindstrom JM, Lambert EH, Lennon VA. Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062 [Abstract] [Full Text] [Related]
6. Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Engel AG, Lindstrom JM, Lambert EH, Lennon VA. Neurology; 1977 Apr; 27(4):307-15. PubMed ID: 557772 [Abstract] [Full Text] [Related]
7. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis. Fumagalli G, Engel AG, Lindstrom J. J Neuropathol Exp Neurol; 1982 Nov; 41(6):567-79. PubMed ID: 6982313 [Abstract] [Full Text] [Related]
8. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. Lindstrom JM, Engel AG, Seybold ME, Lennon VA, Lambert EH. J Exp Med; 1976 Sep 01; 144(3):739-53. PubMed ID: 182897 [Abstract] [Full Text] [Related]
9. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. Sahashi K, Engel AG, Lambert EH, Howard FM. J Neuropathol Exp Neurol; 1980 Mar 01; 39(2):160-72. PubMed ID: 7373347 [Abstract] [Full Text] [Related]
10. Morphological observations on motor end-plates in rabbits with experimental myasthenia. Thornell LE, Sjöström M, Mattsson CH, Heilbronn E. J Neurol Sci; 1976 Oct 01; 29(2-4):389-410. PubMed ID: 978217 [Abstract] [Full Text] [Related]
11. Limb muscle endplates in ocular myasthenia gravis: quantitative ultrastructural study. Tsujihata M, Hazama R, Ishii N, Ide Y, Mori M, Takamori M. Neurology; 1979 May 01; 29(5):654-61. PubMed ID: 571563 [Abstract] [Full Text] [Related]
12. Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor. Gomez CM, Wollmann RL, Richman DP. Acta Neuropathol; 1984 May 01; 63(2):131-43. PubMed ID: 6610275 [Abstract] [Full Text] [Related]
13. Ultrastructural study of the motor end-plate in botulism and Lambert-Eaton myasthenic syndrome. Tsujihata M, Kinoshita I, Mori M, Mori K, Shirabe S, Satoh A, Nagataki S. J Neurol Sci; 1987 Nov 01; 81(2-3):197-213. PubMed ID: 3694228 [Abstract] [Full Text] [Related]
14. Steroid treatment for experimental autoimmune myasthenia gravis. Barone DA, Lambert DH, Poser CM. Arch Neurol; 1980 Oct 01; 37(10):663-6. PubMed ID: 7425891 [Abstract] [Full Text] [Related]
15. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates. Hohlfeld R, Sterz R, Kalies I, Peper K, Wekerle H. Pflugers Arch; 1981 May 01; 390(2):156-60. PubMed ID: 6264388 [Abstract] [Full Text] [Related]
19. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis. Kelly JJ, Lambert EH, Lennon VA. Ann Neurol; 1978 Jul 01; 4(1):67-72. PubMed ID: 211931 [Abstract] [Full Text] [Related]
20. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle. Johnson BR, Kim YI, Sanders DB. J Neurol Sci; 1983 Jun 01; 59(3):431-40. PubMed ID: 6875609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]